Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two CHF1535 pMDIs on symptom perception in adults with moderate to severe asthma
2021-001449-11Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Device preference and outcome assessment responses. Started Oct 2021; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2021-001449-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001449-11.